Alison Bauerlein Net Worth

The estimated Net Worth of Alison Bauerlein is at least $6.33 Millón dollars as of 1 December 2021. Ms. Bauerlein owns over 546 units of Inogen Inc stock worth over $397,572 and over the last 11 years she sold INGN stock worth over $4,759,404. In addition, she makes $1,170,980 as Executive Vice President - Finance and Chief Financial Officer y Corporate Secretary and Corporate Treasurer at Inogen Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Bauerlein INGN stock SEC Form 4 insiders trading

Alison has made over 46 trades of the Inogen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently she exercised 546 units of INGN stock worth $6,312 on 1 December 2021.

The largest trade she's ever made was exercising 27,630 units of Inogen Inc stock on 9 February 2018 worth over $555,916. On average, Alison trades about 6,905 units every 45 days since 2014. As of 1 December 2021 she still owns at least 34,392 units of Inogen Inc stock.

You can see the complete history of Ms. Bauerlein stock trades at the bottom of the page.

Alison Bauerlein biography

Alison Bauerlein is Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer of Inogen, Inc. Ms. Bauerlein is a co-founder of Inogen and has served as our Chief Financial Officer since 2009 and Executive Vice President, Finance since March 2014. Ms. Bauerlein has also served as Corporate Secretary and Corporate Treasurer since 2002. Ms. Bauerlein previously served as our Vice President, Finance from 2008 until March 2014. Prior to serving in these positions, Ms. Bauerlein also served as Controller with our company from 2008 to 2009 and 2001 to 2004, and the Director of Financial Planning and Analysis from 2004 to 2008. Ms. Bauerlein has over 18 years of experience in treasury, finance, accounting, risk management as well as strategic and tactical cost analysis and forecasting. Ms. Bauerlein received a Bachelor of Arts degree in Economics/Mathematics with high honors from the University of California, Santa Barbara.

What is the salary of Alison Bauerlein?

As the Executive Vice President - Finance and Chief Financial Officer y Corporate Secretary and Corporate Treasurer of Inogen Inc, the total compensation of Alison Bauerlein at Inogen Inc is $1,170,980. There are 1 executives at Inogen Inc getting paid more, with Scott Wilkinson having the highest compensation of $2,520,530.

How old is Alison Bauerlein?

Alison Bauerlein is 38, she's been the Executive Vice President - Finance and Chief Financial Officer y Corporate Secretary and Corporate Treasurer of Inogen Inc since 2014. There are 18 older and no younger executives at Inogen Inc. The oldest executive at Inogen Inc is Benjamin Anderson-Ray, 65, who is the Independent Director.

What's Alison Bauerlein's mailing address?

Alison's mailing address filed with the SEC is C/O INOGEN, INC., 301 COROMAR DRIVE, GOLETA, CA, 93117.

Insiders trading at Inogen Inc

Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen y Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.

What does Inogen Inc do?

inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take

Complete history of Ms. Bauerlein stock trades at Inogen Inc

Inogen Inc executives and stock owners

Inogen Inc executives and other stock owners filed with the SEC include:

• Scott Wilkinson,
  President, Chief Executive Officer, Director
• Alison Bauerlein,
  Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer
• Bart Sanford,
  Executive Vice President, Operations
• Byron Myers,
  Executive Vice President of Marketing
• Brenton Taylor,
  Executive Vice President - Engineering
• Dr. Stanislav Glezer M.D., MBA,
  Exec. VP & CTO
• Alison Perry Bauerlein,
  Co-Founder
• Bart Sanford,
  Exec. VP of Operations
• Heath Lukatch,
  Independent Chairman of the Board
• Heather Rider,
  Independent Director
• R. Scott Greer,
  Independent Director
• Loren McFarland,
  Independent Director
• Benjamin Anderson-Ray,
  Independent Director
• Raymond Huggenberger,
  Independent Director
• Matt Bacso,
  IR Contact Officer
• Scott Beardsley,
  Independent Director
• Arron Retterer,
  Executive Vice President of Sales
• Jennifer Yi Boyer,
  Exec. VP & Chief HR Officer
• Agnes Lee,
  Sr. VP of Investor Relations & Strategic Planning
• Kristin A. Caltrider,
  Exec. VP, CFO & Treasurer
• Matthew Pigeon,
  Investor Relations Officer
• George J. Parr,
  Exec. VP & Chief Commercial Officer
• Jason Somer,
  Exec. VP, Gen. Counsel & Corp. Sec.
• Matthew James Bacso C.F.A.,
  Investor Relations & Corp. Devel. Mang.
• Michael K. Sergesketter,
  Interim Chief Financial Officer
• Nabil Shabshab,
  CEO, Pres & Director
• Kevin M King,
  
• Matt Scribner,
  See Remarks
• George J Parr,
  Chief Commercial Officer
• William J Phd Link,
  Director
• Ventures Ii Llc Versant Ven...,
  
• Kristin A. Caltrider,
  EVP, CFO and Treasurer
• Ventures Ii Llc Versant Ven...,
  
• Ventures Ii Llclink William...,
  
• Ventures Ii Lp Arboretum Ve...,
  
• Stephen E. Cooper,
  Director
• Ventures Ii Llc Versant Ven...,
  
• Ventures Ii Llc Versant Ven...,
  
• Ventures Ii Llc Versant Ven...,
  
• Holdings A/S Novo,
  10% owner
• Charles E Larsen,
  Director
• Timothy Petersen,
  Director
• Ventures Ii Llc Versant Ven...,
  
• Kevin Raymond Merrill Smith,
  CEO and President
• Kristen Miranda,
  Director
• Nabil Shabshab,
  CEO and President
• Stanislav Glezer,
  EVP, R&D & Chief Med. Officer
• Jason Somer,
  EVP, Gen. Counsel & Secretary
• Michael J. Bourque,
  EVP, CFO & Treasurer
• Elizabeth Mora,
  
• Thomas A. West,
  
• Mary Kay Ladone,
  
• Glenn S Boehnlein,
  
• Kevin P. Smith,
  EVP, Bus Dev, GC & Sec